Since 2019 Jim has applied a key tenant of his leadership style, “go the extra mile”, to lead the Parexel Biotech division and directly manage its global sales function. Known as a change agent who keeps the patient at the heart of everything he does, Jim has defined what excellence in leadership looks like and driven the success of this fully dedicated and cross-departmental division.
In 2022, PharmaVoice recognized Jim as a disruptor and one of a distinguished group of honorees who are pushing the industry forward. As Global Head of the Biotech division, Jim works closely with executive leadership teams in small, emerging, and mid-sized customers, providing guidance to help them stay at the forefront of industry trends in clinical development so their work makes a deep and lasting impact.
Prior to leading Parexel Biotech, Jim was an Enterprise Account Lead for two of the largest customer accounts at Parexel. This included successes in growth and change management where one partnership was renewed for a second 5-year term and the second partnership was built and launched from the ground up. He joined Parexel in 2010 as Vice President of North America Business Development and was later promoted to Corporate Vice President in 2013.
Jim has 25 years of pharmaceutical industry experience and 22 years of CRO experience. Before joining Parexel, his CRO work included Kendle International (now Syneos Health) 2003 – 2010, and SCIREX Corporation (now Premier Research) 2001 – 2003. Jim began his career in cerebrovascular research, which produced a publication in the Journal of Cerebral Blood Flow and Metabolism.
In 2022, PharmaVoice recognized Jim as a disruptor and one of a distinguished group of honorees who are pushing the industry forward. As Global Head of the Biotech division, Jim works closely with executive leadership teams in small, emerging, and mid-sized customers, providing guidance to help them stay at the forefront of industry trends in clinical development so their work makes a deep and lasting impact.
Prior to leading Parexel Biotech, Jim was an Enterprise Account Lead for two of the largest customer accounts at Parexel. This included successes in growth and change management where one partnership was renewed for a second 5-year term and the second partnership was built and launched from the ground up. He joined Parexel in 2010 as Vice President of North America Business Development and was later promoted to Corporate Vice President in 2013.
Jim has 25 years of pharmaceutical industry experience and 22 years of CRO experience. Before joining Parexel, his CRO work included Kendle International (now Syneos Health) 2003 – 2010, and SCIREX Corporation (now Premier Research) 2001 – 2003. Jim began his career in cerebrovascular research, which produced a publication in the Journal of Cerebral Blood Flow and Metabolism.
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
